BSE filing, NSE: VASWANI. Summary written from the filing by ALFA Finder's alert engine.
Vaswani Industries Ltd: key numbers
- Share price
- ₹39.05
- Market cap
- ₹135.1 Cr
- Revenue (annual)
- ₹467.4 Cr
- Net profit (annual)
- ₹4.24 Cr
- P/E (TTM)
- -2161.0×Sector 16.8×
- Promoter holding
- 62.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaswani Industries Ltd
All →Vaswani Industries Preferential Issue
Vaswani Industries promoter group member Smt. Jyotsna Vaswani disclosed receiving 76,975 shares via preferential allotment. Her stake rose from nil to 0.22%.
Vaswani Industries Preferential Issue
Vaswani Industries board approved allotment of 16,45,000 equity shares at ₹60/share to seven promoter-group members, raising ₹9.87 Crore. Shares carry an 18-month lock-in.
- Value
- ₹9.87 Cr
Vaswani Industries Preferential Issue
Vaswani Industries received in-principle approval from BSE and NSE for a preferential issue of 16,45,000 shares to promoters. The minimum issue value is Rs. 9.87 Crore.
- Value
- ₹9.87 Cr
Vaswani Industries Other Announcement
Vaswani Industries Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per SEBI Regulation 31(1)(b).
Vaswani Industries Annual General Meeting
Vaswani Industries Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business items as scheduled.
Vaswani Industries Annual Report
Vaswani Industries Limited filed its Annual Report for FY 2025-26, incorporating the notice for the 23rd Annual General Meeting.
Other capital structure change announcements
All →Acetech E-Commerce Capital Structure Change
Acetech E-Commerce submitted a Draft Letter of Offer for a proposed Rights Issue of equity shares up to Rs. 4000 Lakhs. The filing is a preliminary rights-issue step with issue price and ratio still blank.
- Value
- ₹40.00 Cr
Indrayani Biotech Capital Structure Change
Indrayani Biotech allotted 83,64,036 rights equity shares at Rs 15 (75,03,333 fully paid) and Rs 3.75 (8,60,703 partly paid). Issue receipts total about Rs 11.58 Crore.
- Value
- ₹11.58 Cr
Shlokka Dyes Capital Structure Change
Shlokka Dyes proposed raising its authorised capital to 2.9 crore shares, pending approval at a 28 November 2026 meeting. No fresh capital has been raised yet.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.
DCW Capital Structure Change
DCW Ltd bought back 155,000 equity shares on NSE on 03-Nov-2026 at an average price of Rs.45.18. The daily report puts the day's buyback spend at about Rs.0.70 Crore.
- Value
- ₹0.70 Cr
NCL Research and Financial Services Capital Structure Change
GCM Capital Advisors and PACs disclosed selling 8,00,000 NCL Research shares, reducing holding to 5.49%. Non-promoter transaction, no consideration stated.